ID | 110894 |
Author |
Tarashima, Noriko
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Ando, Hidenori
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Kojima, Takamitsu
Tokushima University
Kinjo, Nozomi
Tokushima University
Hashimoto, Yosuke
Tokushima University
Furukawa, Kazuhiro
Tokushima University
|
Keywords | 4′-thioDNA
innate immune response
RNA interference
shRNA
TLR9
|
Content Type |
Journal Article
|
Description | The development of a versatile technique to induce RNA interference (RNAi) without immune stimulation in vivo is of interest as existing approaches to trigger RNAi, such as small interfering RNA (siRNA) and plasmid DNA (pDNA) expressing short hairpin RNA (shRNA), present drawbacks arising from innate immune stimulation. To overcome them, an intelligent shRNA expression device (iRed) designed to induce RNAi was developed. The minimum sequence of iRed encodes only the U6 promoter and shRNA. A series of iRed comprises a polymerase chain reaction (PCR)-amplified 4′-thioDNA in which any one type of adenine (A), guanine (G), cytosine (C), or thymine (T) nucleotide unit was substituted by each cognate 4′-thio derivatives, i.e., dSA iRed, dSG iRed, dSC iRed, and ST iRed respectively. Each modified iRed acted as a template to transcribe shRNA with RNAi activity. The highest shRNA yield was generated using dSC iRed that exerted gene silencing activity in an orthotopic mouse model of mesothelioma. Reducing the minimal structure required to transcribe shRNA and the presence of the 4′-thiomodification synergistically function to abrogate innate immune response induced by dsDNA. The iRed will introduce a new approach to induce RNAi without inducing a detectable innate immune response.
|
Journal Title |
Molecular Therapy - Nucleic Acids
|
ISSN | 21622531
|
Publisher | nature
|
Volume | 5
|
Start Page | e274
|
Sort Key | e274
|
Published Date | 2016-01-05
|
Remark | © 2016 Tarashima et al. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article′s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http:// creativecommons.org/licenses/by/4.0/
|
EDB ID | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Pharmaceutical Sciences
|